Skip to content
Research Article Open access CC BY 3.0

A Case of Atypical Hemolytic Uremic Syndrome Superimposed on Behcet’s Disease

T. Sakaci, E. Ahbap, M. Toprak, M. Sevinc, T. Basturk, Y. Koc, S. Akpinar, A. Ozagari, Y. C. Koksal, E. Kara, C. Akgol, Z. Atan Ucar, T. Sahutoglu, F. Bayraktar Caglayan, A. Unsal

International Journal of Medical and Pharmaceutical Case Reports · pp. 17–23 · Published 3 Aug 2014

10.9734/IJMPCR/2014/11938

Abstract

Behcet’s disease is a disorder that involves oral aphthous with genital ulcer, skin lesions, gastrointestinal, vascular, neurological diseases and systemic symptoms such as arthritis. Thrombophilia and vasculitis which may involve any vessel play a role in pathogenesis. aHUS is a syndrome which is characterized by microangiopathic hemolytic anemia, thrombocytopenia and renal failure. We would like to report a case of aHUS in a patient with Behcet’s Disease. 43 year old male patient was admitted to the emergency department with dyspnea for 3 days. In his medical history, 10 years ago Behcet’s Disease was diagnosed and treated with colchicine. At presentation his blood pressure was 140/80mm Hg, heart rate 116/min, respiratory rate 16/min and body temperature 98.9ºF. Laboratory studies revealed microangiopathic hemolytic anemia, thrombocytopenia, acute renal insufficiency, increaded serum bilirubin and lactate dehydrogenase levels, decreased haptoglobulin level leading to suspicion of TMA. Peripheral blood smear was significant for common schistocytes, anisocytosis and thrombocytopenia which were also suggestive for thrombotic microangiopathy. ADAMTS13 level was normal. Pathogenic bacteria in stool microscopy and culture were not available. The patient underwent kidney biopsy consistent with TMA. All symptoms were consistent with a diagnosis of aHUS; 1gr/d methylprednisolone was administered for 3 days with 40mg/d steroid maintenance afterwards. Plasmapheresis therapy was done for 15 times. On the 12th day of treatment, the response was dramatic. Dyspnea was disappeared, hemoglobin increased, platelet number and LDH level normalized, and creatinine was better. aHUS is a disease with high mortality that response dramatically to plasmapheresis and immunsuppressive therapy. Without any other predisposing factor in Behcet’s Disease, aHUS may develop de novo.

Behcet’s disease atypical hemolytic uremic syndrome acute renal failure plasmaphresis

References (10)

  1. 1 Atypical hemolytic uremic syndrome [DOI]
  2. 2 Beh�et's disease [DOI]
  3. 3 Atypical Hemolytic–Uremic Syndrome [DOI]
  4. 4 Complement disorders and hemolytic uremic syndrome [DOI]
  5. 5 Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades-Behçet's disease in Greece.
  6. 6 A Case of Behçet's Disease with Pericarditis, Thrombotic Thrombocytopenic Purpura, Deep Vein Thrombosis and Coronary Artery Pseudo Aneurysm [DOI]
  7. 7 Thrombotic thrombocytopenic purpura in a patient with Behçet's disease [DOI]
  8. 8 Hemolytic uremic syndrome in patients with Behçet's disease treated with cyclosporin A: report of 2 cases.
  9. 9 Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura in a Patient with Behçet’s Disease Treated with Cyclosporin [DOI]
  10. 10 Haemolytic uraemic syndrome during cyclosporin therapy for Behcet's disease. [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

55

Page views

0

PDF downloads

13

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.